Liberum is pleased to announce its appointment as Joint Corporate Broker to Malin Corporation Plc.
Malin invests in and supports life sciences companies developing science and technology to deliver transformative outcomes for patients and create value for shareholders.
The company focuses on oncology, immunology and genetic diseases where they believe innovative life science and healthcare technologies will deliver transformative treatments for patients.
Malin raised €330m in 2015 through its IPO on the European Securities Market of Euronext Dublin (”ESM”).
Liberum has been appointed as the Company’s Joint Corporate Broker alongside Davy, Malin’s current ESM adviser and broker.
Investment Banking - Bidhi Bhoma, Euan Brown, Laura Hamilton
Research - Alistair Campbell, Graham Doyle
Sales - Lisa Tugwell